Immunocore Holdings Stock Profit Margin
| IMCR Stock | USD 58.10 0.36 0.62% |
Immunocore Holdings fundamentals help investors to digest information that contributes to Immunocore Holdings' financial success or failures. It also enables traders to predict the movement of Immunocore Stock. The fundamental analysis module provides a way to measure Immunocore Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immunocore Holdings stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (0.22) | (0.23) |
Immunocore | Profit Margin |
Immunocore Holdings Company Profit Margin Analysis
Immunocore Holdings' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Immunocore Holdings Profit Margin | (0.22) % |
Most of Immunocore Holdings' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immunocore Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Immunocore Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Immunocore Holdings is extremely important. It helps to project a fair market value of Immunocore Stock properly, considering its historical fundamentals such as Profit Margin. Since Immunocore Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immunocore Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immunocore Holdings' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Immunocore Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Immunocore Holdings has a Profit Margin of -0.2217%. This is 98.02% lower than that of the Biotechnology sector and 99.04% lower than that of the Health Care industry. The profit margin for all United States stocks is 82.54% lower than that of the firm.
Immunocore Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immunocore Holdings' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immunocore Holdings could also be used in its relative valuation, which is a method of valuing Immunocore Holdings by comparing valuation metrics of similar companies.Immunocore Holdings is currently under evaluation in profit margin category among related companies.
Immunocore Holdings Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immunocore Holdings from analyzing Immunocore Holdings' financial statements. These drivers represent accounts that assess Immunocore Holdings' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immunocore Holdings' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 889.4B | 1.0B | 1.1B | 2.2B | 3.3T | 3.5T | |
| Enterprise Value | 889.4B | 938.8M | 903.7M | 1.9B | 3.3T | 3.5T |
Immunocore Fundamentals
| Return On Equity | -0.16 | ||||
| Return On Asset | -0.0674 | ||||
| Profit Margin | (0.22) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 2.55 B | ||||
| Shares Outstanding | 50.01 M | ||||
| Shares Owned By Insiders | 9.62 % | ||||
| Shares Owned By Institutions | 81.23 % | ||||
| Number Of Shares Shorted | 4.09 M | ||||
| Price To Book | 6.09 X | ||||
| Price To Sales | 11.29 X | ||||
| Revenue | 249.43 M | ||||
| Gross Profit | 54.11 M | ||||
| EBITDA | (38.47 M) | ||||
| Net Income | (55.29 M) | ||||
| Cash And Equivalents | 208.06 M | ||||
| Cash Per Share | 4.74 X | ||||
| Total Debt | 84.03 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 3.98 X | ||||
| Book Value Per Share | 7.42 X | ||||
| Cash Flow From Operations | 2.94 M | ||||
| Short Ratio | 10.64 X | ||||
| Earnings Per Share | (1.41) X | ||||
| Target Price | 86.07 | ||||
| Number Of Employees | 497 | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 2.92 B | ||||
| Total Asset | 597 M | ||||
| Retained Earnings | (744.67 M) | ||||
| Working Capital | 389.8 M | ||||
| Net Asset | 597 M |
About Immunocore Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immunocore Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunocore Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunocore Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Immunocore Holdings Investors Sentiment
The influence of Immunocore Holdings' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunocore. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Immunocore Holdings' public news can be used to forecast risks associated with an investment in Immunocore. The trend in average sentiment can be used to explain how an investor holding Immunocore can time the market purely based on public headlines and social activities around Immunocore Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Immunocore Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunocore Holdings' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Immunocore Holdings' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Immunocore Holdings.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunocore Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunocore Holdings' short interest history, or implied volatility extrapolated from Immunocore Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Immunocore Holdings Piotroski F Score and Immunocore Holdings Altman Z Score analysis. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.Note that the Immunocore Holdings information on this page should be used as a complementary analysis to other Immunocore Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Immunocore Stock analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Immunocore Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (1.41) | Revenue Per Share 5.102 | Quarterly Revenue Growth 0.122 | Return On Assets (0.07) |
The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.